Re: Response letter to Sanofi's communication related to "the budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States".
Sepehr FarahbakhshianTimothy J InocencioGregory PoormanEkaterina WrightRavi Ramesh PathakMichael BullanoPublished in: Journal of medical economics (2023)
Keyphrases